Sanyou Bio announces Series C of under approximately $15M, funded by Zero2IPO Industry Investment
Sanyou Bio announces Series C of under approximately $15M, funded by Zero2IPO Industry Investment
November 9, 2026 issuer announcement: Sanyou Bio completed an amount-qualified Series C exclusively financed by Zero2IPO Industry Investment, managed by Zero2IPO Group. At the November 9 ECB rates, the reported ceiling converts to less than approximately $15M; the exact round sum and legal close date are not disclosed. Company-reported cumulative financing below about $45M is NOT new Series C proceeds.